Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies
Philipp Königshofer, Benedikt Hofer, Ksenia Brusilovskaya, et al.
Hepatology (2021) Vol. 75, Iss. 3, pp. 610-622
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
Georg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 1041-1052
Open Access | Times Cited: 55
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
Rafael Paternostro, Wilhelmus J. Kwanten, Benedikt Hofer, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 827-836
Open Access | Times Cited: 12
Hypertension inhibition by Dubosiella newyorkensis via reducing pentosidine synthesis
Tianhao Liu, Minghao Chen, Chenyang Zhang, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
The role and mechanism of hydrogen sulfide in liver fibrosis
Shaoyu Mao, Xuemei Wang, Miaoqing Li, et al.
Nitric Oxide (2024) Vol. 145, pp. 41-48
Closed Access | Times Cited: 6
The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
Lukas Hartl, Benedikt Rumpf, Oliver Domenig, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis
Travis Owen, Guido Carpino, Lixian Chen, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 16, Iss. 4, pp. 513-540
Open Access | Times Cited: 12
Neutrophil extracellular traps-induced pyroptosis of liver sinusoidal endothelial cells exacerbates intrahepatic coagulation in cholestatic mice
Muxin Yu, Chuwei Zheng, Xiaowen Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167700-167700
Open Access
Author's Reply: “Comment on: Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis”
Benedikt Hofer, Thomas Reiberger
Digestive and Liver Disease (2025)
Closed Access
Progress in Non-Invasive Assessment of Portal Hypertension in Cirrhosis
小倩 吴
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 1479-1486
Closed Access
Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension
Oleksandr Petrenko, Philipp Königshofer, Ksenia Brusilovskaya, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109301-109301
Open Access | Times Cited: 3
Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation
Yarong Hao, Zhiyuan Hao, Xin Zeng, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 788-797
Closed Access | Times Cited: 3
Portal hypertension and its prognostic implications in patients with Wilson's disease
Lukas Burghart, Péter Ferenci, Alexander Y. Petrenko, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 2, pp. 257-266
Open Access | Times Cited: 2
Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice
Kerui Fan, Xinyan Zan, Ying Zhi, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 607, pp. 103-109
Closed Access | Times Cited: 12
Impact of continued alcohol use on liver-related outcomes of alcohol-associated cirrhosis: a retrospective study of 440 patients
Georgios Kalambokis, Nikolleta Chouliara, Ilias Tsiakas, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 36, Iss. 1, pp. 89-96
Closed Access | Times Cited: 5
Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension
Kateřina Žížalová, Barbora Nováková, Marek Vecka, et al.
Liver International (2022) Vol. 43, Iss. 4, pp. 888-895
Closed Access | Times Cited: 8
Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models
Huimin Dong, Lu Zhao, Hengchang Sun, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Enhancing liver cirrhosis varices and CSPH risk prediction with spleen stiffness measurement using 100-Hz probe
Jeong‐Ju Yoo, Sun Ah Maeng, Young Woon Chang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis
Benedikt Hofer, Benedikt Simbrunner, Philipp Königshofer, et al.
Digestive and Liver Disease (2024)
Open Access | Times Cited: 1
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis
Benedikt Hofer, Benedikt Simbrunner, Philipp Königshofer, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
Chondroitin Sulfate Protects the Liver in an Experimental Model of Extra-Hepatic Cholestasis Induced by Common Bile Duct Ligation
Pedro Luiz Rodrigues Guedes, Carolina Prado de França Carvalho, Adriana Aparecida Ferraz Carbonel, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 654-654
Open Access | Times Cited: 7
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 105-109
Open Access | Times Cited: 7
Portal hypertension is a key determinant of the risk for liver-related events in non-alcoholic fatty liver disease
Rafael Paternostro, Wilhelmus J. Kwanten, Thomas Reiberger
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. e102-e104
Open Access | Times Cited: 6
Assessment of compensated advanced chronic liver disease based on serum bile acids in chronic hepatitis B patients
Fei Chen, Yaning Yao, Zhen Li, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Relationship Between Spleen Pathologic Changes and Spleen Stiffness in Portal Hypertension Rat Model
Lingyue Du, Huan Deng, Xiaoting Wu, et al.
Ultrasound in Medicine & Biology (2023) Vol. 50, Iss. 2, pp. 216-223
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top